| {"0": "Sphingolipid metabolism overview", "1": "Sphingolipid metabolism integrated pathway", "2": "Sphingolipid pathway", "3": "Mitochondrial complex iv assembly", "4": "Sphingolipid metabolism in senescence", "5": "Ferroptosis", "6": "Physiological and pathological hypertrophy of the heart", "7": "Adipogenesis", "8": "Metapathway biotransformation phase i and ii", "9": "Cholesterol metabolism with bloch and kandutschrussell pathways", "10": "Electron transport chain oxphos system in mitochondria", "11": "Mitochondrial complex i assembly model oxphos system", "12": "Apoptosis modulation and signaling", "13": "Allograft rejection", "14": "Neural crest cell migration in cancer", "15": "Nonalcoholic fatty liver disease", "16": "Cholesterol biosynthesis pathway", "17": "Oxidative phosphorylation", "18": "Nrp1triggered signaling pathways in pancreatic cancer", "19": "Il7 signaling pathway", "20": "Il9 signaling pathway", "21": "Epo receptor signaling", "22": "Hepatitis c and hepatocellular carcinoma", "23": "Genes related to primary cilium development based on crispr", "24": "Vitamin d receptor pathway", "25": "Serotonin htr1 group and fos pathway", "26": "Pdgfrbeta pathway", "27": "4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression", "28": "Folate metabolism", "29": "Envelope proteins and their potential roles in edmd physiopathology", "30": "Glucocorticoid receptor pathway"} |